EyePoint, Inc. (EYPT) stock
EYPTNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
$0.30−0.01 (-3.80%)
Close on Nov 17, 2026Market cap $25.51MP/E –Yield –
EyePoint operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
EyePoint's operating cash flow for the twelve months ending Jun 30, 2026 was -$267.30M. For fiscal 2025 it was -$240.11M. The highest annual figure on record is $10.30M in fiscal 2015.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$240.11M | – |
| FY2024 | Dec 31, 2024 | -$126.23M | -6832.1% |
| FY2023 | Dec 31, 2023 | $1.88M | – |
| FY2022 | Dec 31, 2022 | -$65.01M | – |
| FY2021 | Dec 31, 2021 | -$50.10M | – |
| FY2020 | Dec 31, 2020 | -$14.44M | – |
| FY2018 | Jun 30, 2018 | -$21.91M | – |
| FY2017 | Jun 30, 2017 | -$20.49M | – |
| FY2016 | Jun 30, 2016 | -$16.32M | -258.5% |
| FY2015 | Jun 30, 2015 | $10.30M | – |
| FY2014 | Jun 30, 2014 | -$10.67M | – |
| FY2013 | Jun 30, 2013 | -$8.75M | – |
| FY2012 | Jun 30, 2012 | -$9.00M | – |
| FY2011 | Jun 30, 2011 | -$3.17M | -132.0% |
| FY2010 | Jun 30, 2010 | $9.90M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026CQ2 2026 | Jun 30, 2026 | -$62.35M | – |
| Q1 FY2026CQ1 2026 | Mar 31, 2026 | -$80.55M | – |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | -$65.05M | – |
| Q3 FY2025CQ3 2025 | Sep 30, 2025 | -$59.35M | – |
| Q2 FY2025CQ2 2025 | Jun 30, 2025 | -$62.59M | – |
| Q1 FY2025CQ1 2025 | Mar 31, 2025 | -$53.12M | – |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | -$35.85M | – |
| Q3 FY2024CQ3 2024 | Sep 30, 2024 | -$39.03M | – |
| Q2 FY2024CQ2 2024 | Jun 30, 2024 | -$20.18M | -135.4% |
| Q1 FY2024CQ1 2024 | Mar 31, 2024 | -$31.17M | – |
| Q4 FY2023CQ4 2023 | Dec 31, 2023 | -$23.11M | – |
| Q3 FY2023CQ3 2023 | Sep 30, 2023 | -$15.20M | – |
| Q2 FY2023CQ2 2023 | Jun 30, 2023 | $57.02M | – |
| Q1 FY2023CQ1 2023 | Mar 31, 2023 | -$16.84M | – |
| Q4 FY2022CQ4 2022 | Dec 31, 2022 | -$12.59M | – |
| Q3 FY2022CQ3 2022 | Sep 30, 2022 | -$13.14M | – |
| Q2 FY2022CQ2 2022 | Jun 30, 2022 | -$19.12M | – |
| Q1 FY2022CQ1 2022 | Mar 31, 2022 | -$20.16M | – |
| Q4 FY2021CQ4 2021 | Dec 31, 2021 | -$16.67M | -382.7% |
| Q3 FY2021CQ3 2021 | Sep 30, 2021 | -$7.79M | -785.5% |
| Q2 FY2021CQ2 2021 | Jun 30, 2021 | -$10.54M | – |
| Q1 FY2021CQ1 2021 | Mar 31, 2021 | -$15.10M | – |
| Q4 FY2020CQ4 2020 | Dec 31, 2020 | $5.90M | – |
| Q3 FY2020CQ3 2020 | Sep 30, 2020 | $1.14M | – |
| Q2 FY2020CQ2 2020 | Jun 30, 2020 | -$5.12M | – |
| Q1 FY2020CQ1 2020 | Mar 31, 2020 | -$16.35M | – |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | -$6.08M | – |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | -$4.82M | – |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | -$5.04M | – |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | -$5.97M | – |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | -$4.45M | – |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | -$4.54M | – |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | -$5.01M | – |
| Q1 FY2017CQ3 2016 | Sep 30, 2016 | -$6.49M | – |
| Q4 FY2016CQ2 2016 | Jun 30, 2016 | -$4.35M | – |
| Q3 FY2016CQ1 2016 | Mar 31, 2016 | -$4.30M | – |
| Q2 FY2016CQ4 2015 | Dec 31, 2015 | -$3.17M | – |
| Q1 FY2016CQ3 2015 | Sep 30, 2015 | -$4.49M | – |
| Q4 FY2015CQ2 2015 | Jun 30, 2015 | -$3.01M | – |
| Q3 FY2015CQ1 2015 | Mar 31, 2015 | -$3.95M | – |
See a number that looks wrong?